Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Mariam Sylla

Biographic Data

ID9020620
NAMEMariam Sylla
GIVEN NAMESMariam
FAMILY NAMESylla
SIGNATURESYLLA M
AFFILIATIONSUniversity of Bamako
ORCID0000-0001-9967-9356
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS0
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR2008
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Assessing the effects of the Covid-19 pandemic on new ART initiation and viral load access among children and adolescents living with HIV in West Africa

    Open Access•Yao Rodion Konu, Karen Malateste et al.•ARTICLE•Frontiers in Public Health•2025

    Background: Before the COVID-19 pandemic, the pediatric continuum of HIV care lagged behind that of adults. The present study aimed to describe the effects of the COVID-19 pandemic on access to HIV care among children and adolescents (0-19 years) living with HIV (CALHIV) in five West African countries. Methods: Within this observational multicenter study, we conducted an interrupted time series analysis by including all antiretroviral therapy (AR…

  • Disparities in dolutegravir utilisation in children, adolescents and young adults (0–24 years) living with HIV. An analysis of the IeDEA Pediatric West African cohort

    Open Access•Sophie Desmonde, Joycelyn Assimeng Dame et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: We describe the 24-month incidence of Dolutegravir (DTG)-containing antiretroviral treatment (ART) initiation since its introduction in 2019 in West Africa. METHODS: We included all patients aged 0-24 years on ART from nine clinics in Côte d'Ivoire (n=4), Ghana, Nigeria, Mali, Benin, and Burkina Faso. Baseline varied by clinic and was defined as date of first DTG prescription; patients were followed up until database closure/death/l…

  • Development and validation of a novel clinical risk score to predict hypoxaemia in children with pneumonia using the WHO PREPARE dataset

    Open Access•Rainer Tan, Arjun Chandna et al.•ARTICLE•BMJ Global Health•2025

    BACKGROUND: Hypoxaemia predicts mortality at all levels of care, and appropriate management can reduce preventable deaths. However, pulse oximetry and oxygen therapy remain inaccessible in many primary care health facilities. We aimed to develop and validate a simple risk score comprising commonly evaluated clinical features to predict hypoxaemia in 2-59-month-old children with pneumonia. METHODS: Data from seven studies conducted in five countri…

  • Derivation and validation of a novel risk assessment tool to identify children aged 2–59 months at risk of hospitalised pneumonia-related mortality in 20 countries

    Open Access•Chris A Rees, Trevor Colbourn et al.•ARTICLE•BMJ Global Health•2022

    INTRODUCTION: Existing risk assessment tools to identify children at risk of hospitalised pneumonia-related mortality have shown suboptimal discriminatory value during external validation. Our objective was to derive and validate a novel risk assessment tool to identify children aged 2-59 months at risk of hospitalised pneumonia-related mortality across various settings. METHODS: We used primary, baseline, patient-level data from 11 studies, incl…

  • Assembling a global database of child pneumonia studies to inform WHO pneumonia management algorithm

    Open Access•Helena Martin, H Martı́n et al.•ARTICLE•Journal of Global Health•2022

    Background: The existing World Health Organization (WHO) pneumonia case management guidelines rely on clinical symptoms and signs for identifying, classifying, and treating pneumonia in children up to 5 years old. We aimed to collate an individual patient-level data set from large, high-quality pre-existing studies on pneumonia in children to identify a set of signs and symptoms with greater validity in the diagnosis, prognosis, and possible trea…

  • External validation of the Risc, Risc-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumonia

    Open Access•Chris A Rees, Shubhada Hooli et al.•ARTICLE•Journal of Global Health•2021

    BACKGROUND: Existing scores to identify children at risk of hospitalized pneumonia-related mortality lack broad external validation. Our objective was to externally validate three such risk scores. METHODS: We applied the Respiratory Index of Severity in Children (RISC) for HIV-negative children, the RISC-Malawi, and the Pneumonia Etiology Research for Child Health (PERCH) scores to hospitalized children in the Pneumonia REsearch Partnerships to …

  • Satisfaction with health services for STIs, HIV, Aids among a high-risk population in West Africa

    Diane Morin, Gabriel Godin et al.•ARTICLE•AIDS Care•2008

    The goal of this study was to develop an instrument and assess the degree of satisfaction regarding HIV/STIs services for women working in, associated with, or living in or nearby, prostitution environments. This study took place in seven West-African countries (Benin, Burkina Faso, Ghana, Mali, Niger, Senegal, Togo) participating in the West Africa Aids Program (AIDS3). A validated six-dimension questionnaire was used to interview 698 women. The…

No prominent works on this page.

  • Satisfaction with health services for STIs, HIV, Aids among a high-risk population in West Africa

    Diane Morin, Gabriel Godin et al.•ARTICLE•AIDS Care•2008

    The goal of this study was to develop an instrument and assess the degree of satisfaction regarding HIV/STIs services for women working in, associated with, or living in or nearby, prostitution environments. This study took place in seven West-African countries (Benin, Burkina Faso, Ghana, Mali, Niger, Senegal, Togo) participating in the West Africa Aids Program (AIDS3). A validated six-dimension questionnaire was used to interview 698 women. The…

  • External validation of the Risc, Risc-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumonia

    Open Access•Chris A Rees, Shubhada Hooli et al.•ARTICLE•Journal of Global Health•2021

    BACKGROUND: Existing scores to identify children at risk of hospitalized pneumonia-related mortality lack broad external validation. Our objective was to externally validate three such risk scores. METHODS: We applied the Respiratory Index of Severity in Children (RISC) for HIV-negative children, the RISC-Malawi, and the Pneumonia Etiology Research for Child Health (PERCH) scores to hospitalized children in the Pneumonia REsearch Partnerships to …

  • Derivation and validation of a novel risk assessment tool to identify children aged 2–59 months at risk of hospitalised pneumonia-related mortality in 20 countries

    Open Access•Chris A Rees, Trevor Colbourn et al.•ARTICLE•BMJ Global Health•2022

    INTRODUCTION: Existing risk assessment tools to identify children at risk of hospitalised pneumonia-related mortality have shown suboptimal discriminatory value during external validation. Our objective was to derive and validate a novel risk assessment tool to identify children aged 2-59 months at risk of hospitalised pneumonia-related mortality across various settings. METHODS: We used primary, baseline, patient-level data from 11 studies, incl…

  • Assembling a global database of child pneumonia studies to inform WHO pneumonia management algorithm

    Open Access•Helena Martin, H Martı́n et al.•ARTICLE•Journal of Global Health•2022

    Background: The existing World Health Organization (WHO) pneumonia case management guidelines rely on clinical symptoms and signs for identifying, classifying, and treating pneumonia in children up to 5 years old. We aimed to collate an individual patient-level data set from large, high-quality pre-existing studies on pneumonia in children to identify a set of signs and symptoms with greater validity in the diagnosis, prognosis, and possible trea…

  • Assessing the effects of the Covid-19 pandemic on new ART initiation and viral load access among children and adolescents living with HIV in West Africa

    Open Access•Yao Rodion Konu, Karen Malateste et al.•ARTICLE•Frontiers in Public Health•2025

    Background: Before the COVID-19 pandemic, the pediatric continuum of HIV care lagged behind that of adults. The present study aimed to describe the effects of the COVID-19 pandemic on access to HIV care among children and adolescents (0-19 years) living with HIV (CALHIV) in five West African countries. Methods: Within this observational multicenter study, we conducted an interrupted time series analysis by including all antiretroviral therapy (AR…

  • Disparities in dolutegravir utilisation in children, adolescents and young adults (0–24 years) living with HIV. An analysis of the IeDEA Pediatric West African cohort

    Open Access•Sophie Desmonde, Joycelyn Assimeng Dame et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: We describe the 24-month incidence of Dolutegravir (DTG)-containing antiretroviral treatment (ART) initiation since its introduction in 2019 in West Africa. METHODS: We included all patients aged 0-24 years on ART from nine clinics in Côte d'Ivoire (n=4), Ghana, Nigeria, Mali, Benin, and Burkina Faso. Baseline varied by clinic and was defined as date of first DTG prescription; patients were followed up until database closure/death/l…

  • Development and validation of a novel clinical risk score to predict hypoxaemia in children with pneumonia using the WHO PREPARE dataset

    Open Access•Rainer Tan, Arjun Chandna et al.•ARTICLE•BMJ Global Health•2025

    BACKGROUND: Hypoxaemia predicts mortality at all levels of care, and appropriate management can reduce preventable deaths. However, pulse oximetry and oxygen therapy remain inaccessible in many primary care health facilities. We aimed to develop and validate a simple risk score comprising commonly evaluated clinical features to predict hypoxaemia in 2-59-month-old children with pneumonia. METHODS: Data from seven studies conducted in five countri…

Medicine (7 works) · Internal Medicine (5 works) · Intensive care medicine (4 works) · Pediatrics (4 works) · Pneumonia (4 works) · Pneumonia and Respiratory Infections (4 works) · HIV/AIDS Research and Interventions (3 works) · Advanced Causal Inference Techniques (2 works) · Emergency Medicine (2 works) · Environmental health (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae